Exosomes are natural extracellular nanovesicles (30–150 nm in diameter) with the ability to
interact with and be taken up by specific cells. They are being explored as delivery systems …

Long non-coding RNAs (lncRNAs) are a class of RNA transcripts more than 200 nucleotides
in length that play crucial roles in cancer development and progression. With the rapid …

The management of acute kidney injury (AKI) imposes a significant medical burden. Due to
the lack of effective drug transport vehicles, the administration of therapeutic agents for AKI …

Oncolytic viruses (OV) are an attractive prospect due to their dual attack mechanism of direct
cell lysis and potentiation of an antitumor immune response. Various oncolytic viral vectors …

Nanomedicines are innovative and promising, but lack a convincing clinical presence. Thus,
biomimetic nanoparticles (BMNPs) have been designed with functionalizations which …

Preclinical and clinical studies have demonstrated that precision therapy has a broad variety
of treatment applications, making it an interesting research topic with exciting potential in …

Intracellular protein delivery has the potential to revolutionize cell-biological research and
medicinal therapy, with broad applications in bioimaging, disease treatment, and genome …

The progress in human disease treatment can be greatly advanced through the
implementation of nanomedicine. This approach involves targeted and cell-specific therapy …

Biomimetic delivery systems (BDSs), inspired by the intricate designs of biological systems,
have emerged as a groundbreaking paradigm in nanomedicine, offering unparalleled …

Glioblastoma (GBM) stands for the most common and aggressive type of brain tumour in
adults. It is highly invasive, which explains its short rate of survival. Little is known about its …